Key Takeaways
- Scimplify has raised $40 million in Series B funding, co-led by Accel and Bertelsmann India Investments, with participation from UMI and existing investors Omnivore and 3one4 Capital.
- The funding will accelerate Scimplify’s global expansion, with exports already reaching 16 countries and plans to enter new industry segments.
- Scimplify’s full-stack approach integrates in-house R&D with a network of over 200 specialized manufacturing plants, offering a flexible alternative to traditional specialty chemical manufacturing.
- The company’s model is addressing supply chain disruptions by providing an alternative to dependency on China for specialty chemicals, particularly for industries in the U.S., Europe, and Japan.
- Scimplify aims to build a global R&D-driven manufacturing network, adapting to evolving customer needs and geopolitical shifts in supply chains.
Scimplify Expands Global Specialty Chemical Manufacturing with $40M Series B
Scaling a Flexible, R&D-Led Production Model
Scimplify, a company rethinking specialty chemical manufacturing and supply chains, has raised $40 million in a Series B funding round. The investment was co-led by Accel and Bertelsmann India Investments, with participation from UMI, Omnivore, and 3one4 Capital. This latest round brings Scimplify’s total funding to $54 million, positioning the company to scale operations, expand geographically, and accelerate exports beyond its current 16-country reach.
The company was founded in 2023 by Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra, who leveraged a decade of experience in bringing Indian factories to global customers. Scimplify consolidates the specialty chemical manufacturing process under one platform, integrating R&D with a network of over 200 specialized plants across low-cost regions. This full-stack approach eliminates the capital-intensive and rigid production constraints of traditional chemical manufacturing.
“Global supply chains are shifting like never before. Specialty chemical manufacturers have invested millions in facilities that can only produce a handful of compounds, often running at partial capacity while lacking R&D capabilities. We’ve flipped this model, connecting our scientific teams with hundreds of manufacturing plants to create a responsive ecosystem that can adapt as market needs shift.” — Sachin Santhosh, Co-Founder, Scimplify
Addressing Geopolitical Shifts in Supply Chains
Providing a Resilient Alternative to Chinese Suppliers
As industries worldwide seek to diversify supply chains, Scimplify is offering an alternative to China’s dominance in specialty chemical manufacturing. U.S. and European companies previously dependent on Chinese suppliers are now sourcing from India through Scimplify’s streamlined R&D-led production network.
This flexible model allows companies to scale production dynamically, avoiding the risks associated with regional trade restrictions and geopolitical uncertainties. Scimplify customers benefit from:
- Seamless access to specialized chemical production without heavy capital investment.
- A plug-and-play manufacturing approach, integrating R&D, quality assurance, and large-scale production.
- A diversified supply chain, reducing dependency on a single region for critical chemicals.
“The global supply chain for specialty chemicals is at an inflection point. Traditional supply chains lack the flexibility required in today’s geopolitical environment. Scimplify is building an R&D-led global manufacturing network that enables adaptability while driving innovation.” — Rachit Parekh, Principal, Accel
How Scimplify Differentiates from Traditional Chemical Manufacturers
Combining R&D and Scalable Manufacturing
Unlike traditional chemical companies, which rely on fixed production facilities, Scimplify’s flexible network enables customers to quickly adapt to changing demands.
Key differentiators include:
- In-house R&D expertise that provides technical support and formulation development.
- A vast network of 200+ specialized plants, allowing for cost-effective production across different chemical processes.
- Rapid scalability, ensuring that production can adjust in real-time based on customer needs.
- Cross-industry application, serving life sciences, crop sciences, and industrial chemical markets.
“Each specialty chemical requires significant scientific expertise and R&D investment. We’ve built a model that brings together top scientific minds with highly specialized manufacturing plants, creating a chemistry powerhouse capable of solving complex industry challenges.” — Sachin Santhosh, Co-Founder, Scimplify
Investor Confidence in Scimplify’s Growth Potential
Expanding R&D Capabilities and Market Reach
The investment from Accel, Bertelsmann India Investments, and UMI underscores the potential of Scimplify’s scalable, R&D-driven manufacturing model.
“Scimplify’s execution on the ground has been among the best we’ve seen. They are driving not just impressive topline growth but also a rapid multi-country export scale-up and the establishment of a cutting-edge R&D facility in Hyderabad.” — Rohit Sood, Partner, Bertelsmann India Investments
